Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis
Martin A. Walter, Cédric Nesti, Marko Spanjol, et al.
Cochrane library (2021) Vol. 2021, Iss. 11
Open Access | Times Cited: 11

Showing 11 citing articles:

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
Amr Mohamed, Sulin Wu, Mohamed E. Hamid, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 295-295
Open Access | Times Cited: 27
Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell line
Xin Lou, Ye Zeng, Xiaowu Xu, et al.
Human Cell (2022) Vol. 35, Iss. 4, pp. 1248-1261
Closed Access | Times Cited: 17
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Dimitrios Papantoniou, Malin Grönberg, Espen Thiis‐Evensen, et al.
Endocrine Related Cancer (2023) Vol. 30, Iss. 3
Open Access | Times Cited: 7
Incidence trends and survival analysis of appendiceal tumors in the United States: Primarily changes in appendiceal neuroendocrine tumors
Dan Wang, Heming Ge, Yebin Lu, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294153-e0294153
Open Access | Times Cited: 5
Factors Affecting Survival Outcomes in Neuroendocrine Tumor of the Appendix over the Past Two Decades
Vignesh Krishnan Nagesh, Izage Kianifar Aguilar, Daniel Eliáš, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 96-96
Open Access | Times Cited: 1
Surgical management of pancreatic neuroendocrine neoplasms
Piero Alberti, David Martín, Georgios Gemenetzis, et al.
Laparoscopic Endoscopic and Robotic Surgery (2023) Vol. 6, Iss. 3, pp. 83-90
Open Access | Times Cited: 1
Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population
Yuanyuan Liu, Xinyi Yang, Yan Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Risk Factors Associated with the Development of Metastases in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis
Shuzo Kohno, Masahiro Ikegami, Toru Ikegami, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 60-60
Open Access | Times Cited: 3
Diagnosis and Surgical Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: A Literature Review
Shuzo Kohno
Cancer Diagnosis & Prognosis (2022) Vol. 2, Iss. 2, pp. 115-125
Open Access | Times Cited: 2
How do different therapies compare with placebo and with each other in people with pancreatic neuroendocrine tumors (pNETs)?
Sera Tort, Amin Sharifan
Cochrane Clinical Answers (2022)
Closed Access
How do different therapies compare with placebo and with each other in people with gastrointestinal neuroendocrine tumors (gNETs)?
Sera Tort, Amin Sharifan
Cochrane Clinical Answers (2022)
Closed Access
Page 1

Scroll to top